Publication not explained
This publication has not yet been explained in plain language by the author(s). However, you can still read the publication.
If you are one of the authors, claim this publication so you can create a plain language summary to help more people find, understand and use it.
Featured Image
Read the Original
This page is a summary of: Place of Prasugrel, P2Y12 receptor antagonist, in an early invasive treatment of patients with acute coronary syndrome (according to the results of multicenter randomized controlled trial ISAR-REACT 5), Russian Journal of Cardiology, November 2019, Silicea - Poligraf, LLC,
DOI: 10.15829/1560-4071-2019-11-92-97.
You can read the full text:
Contributors
The following have contributed to this page
